{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioequivalence&page=18", "query": { "condition": "Bioequivalence", "page": 18 }, "page_size": 10 }, "pagination": { "page": 18, "page_size": 10, "total_count": 783, "total_pages": 79, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioequivalence&page=19&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioequivalence&page=17&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T07:08:16.112Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01247285", "title": "90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Fluoxetine Hydrochloride", "type": "DRUG" }, { "name": "PROZAC WEEKLY®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2001-05", "completion_date": "2001-07", "has_results": true, "last_update_posted_date": "2011-02-21", "last_synced_at": "2026-10-23T07:08:16.112Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01247285" }, { "nct_id": "NCT00853554", "title": "Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Hydromorphone Hydrochloride tablet 8 mg", "type": "DRUG" }, { "name": "Dilaudid® tablet 8 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mallinckrodt", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2002-12", "completion_date": "2002-12", "has_results": false, "last_update_posted_date": "2016-10-19", "last_synced_at": "2026-10-23T07:08:16.112Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00853554" }, { "nct_id": "NCT00647881", "title": "Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Paroxetine Hydrochloride Controlled-Release Tablets 25 mg", "type": "DRUG" }, { "name": "Paxil CR™ Tablets 25 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2005-04", "completion_date": "2005-05", "has_results": false, "last_update_posted_date": "2024-04-24", "last_synced_at": "2026-10-23T07:08:16.112Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00647881" }, { "nct_id": "NCT00742820", "title": "Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hyperphosphatemia" ], "interventions": [ { "name": "Calcium Acetate Oral Solution 667 mg per 5 mL", "type": "DRUG" }, { "name": "Calcium Acetate 667 mg GelCaps", "type": "DRUG" }, { "name": "Calcium Citrate 950 mg Caplets", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Fresenius Medical Care North America", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 46, "start_date": "2008-08", "completion_date": "2008-11", "has_results": false, "last_update_posted_date": "2009-02-09", "last_synced_at": "2026-10-23T07:08:16.112Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00742820" }, { "nct_id": "NCT01131923", "title": "Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Amlodipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dr. Reddy's Laboratories Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 26, "start_date": "2002-10", "completion_date": "2002-12", "has_results": false, "last_update_posted_date": "2010-06-14", "last_synced_at": "2026-10-23T07:08:16.112Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01131923" }, { "nct_id": "NCT01149486", "title": "Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Losartan potassium/Hydrochlorothiazide", "type": "DRUG" }, { "name": "Hyzaar®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 20, "start_date": "2004-01", "completion_date": "2004-02", "has_results": true, "last_update_posted_date": "2010-12-08", "last_synced_at": "2026-10-23T07:08:16.112Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01149486" }, { "nct_id": "NCT02584257", "title": "Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Mild Persistent Asthma" ], "interventions": [ { "name": "methacholine chloride", "type": "OTHER" }, { "name": "placebo ProAir HFA", "type": "DRUG" }, { "name": "ProAir HFA", "type": "DRUG" }, { "name": "Lupin albuterol HFA MDI", "type": "DRUG" }, { "name": "placebo Lupin albuterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Lupin, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 217, "start_date": "2016-04", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2020-12-04", "last_synced_at": "2026-10-23T07:08:16.112Z", "location_count": 17, "location_summary": "Huntington Beach, California • Mission Viejo, California • Rolling Hills Estates, California + 14 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02584257" }, { "nct_id": "NCT00648011", "title": "Food Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg", "type": "DRUG" }, { "name": "Accuretic™ Tablets 20 mg/25 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2003-08", "completion_date": "2003-09", "has_results": false, "last_update_posted_date": "2024-04-24", "last_synced_at": "2026-10-23T07:08:16.112Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00648011" }, { "nct_id": "NCT00647686", "title": "Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Fentanyl Transdermal System 25 mcg/h + Askina Derm Overlay", "type": "DRUG" }, { "name": "Fentanyl Transdermal System 25 mcg/h", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2006-06", "completion_date": "2006-07", "has_results": false, "last_update_posted_date": "2024-04-23", "last_synced_at": "2026-10-23T07:08:16.112Z", "location_count": 1, "location_summary": "Morgantown, West Virginia", "locations": [ { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00647686" }, { "nct_id": "NCT06942741", "title": "A Study to Evaluate the Effect of Formulation and Food on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-011)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Calderasib OCT", "type": "DRUG" }, { "name": "Calderasib FCT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 52, "start_date": "2025-05-13", "completion_date": "2025-08-04", "has_results": false, "last_update_posted_date": "2026-02-11", "last_synced_at": "2026-10-23T07:08:16.112Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06942741" } ] }